|
Symbol
|
ABVHSQ | RMA3QV | Z0ATQZ | LZQRCH | QXPRCH | RMAKZV | QZKRCH | AEFRTQ | RMA0TV | ADIESQ | RMBXZV | ROMRCH | AFNHTQ | RMB4JV | RMADEV | AFWPTQ | RMB5TV | MBWRCH | RMBTQV | RMB57V |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Multi Reverse Convertible | Multi Vonti | Autocallable Reverse Convertible Defensive worst | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Vonti | Multi Vonti | Worst of Callable Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Multi Vonti | Multi Vonti |
|
Sous-jacent
|
Sika AG / Helvetia Baloise Holding AG / Straumann Hldg. AG / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Galderma Group AG / Sandoz Group AG / SIG Combibloc / VAT Group | Givaudan / Novartis AG / Sandoz Group AG | Alcon / Lonza Group N / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Siegfried Hldg. AG | Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Lonza Group N / Sandoz Group AG / Straumann Hldg. AG | DKSH Hldg. AG / Sandoz Group AG / Siegfried Hldg. AG | Alcon / Sandoz Group AG / UBS Group AG | Galderma Group AG / Lonza Group N / Roche PS / Sandoz Group AG / Straumann Hldg. AG | Galderma Group AG / Lonza Group N / Sandoz Group AG | Givaudan / Novartis AG / Sandoz Group AG | Compagnie Financière Richemont SA / Nestlé S.A. / Partners Group Hldg. AG / Sandoz Group AG | ABB / Sandoz Group AG / Swisscom N | Givaudan / Novartis AG / Sandoz Group AG | Galderma Group AG / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Nestlé S.A. / Roche PS / Sandoz Group AG | Nestlé S.A. / Partners Group Hldg. AG / Sandoz Group AG / VAT Group | Compagnie Financière Richemont SA / Givaudan / Sandoz Group AG / Swiss Prime Site AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
07.10.2026 | 09.11.2026 | 07.09.2026 | 07.08.2029 | 25.08.2027 | 01.09.2028 | 08.09.2026 | 24.09.2027 | 19.11.2026 | 24.11.2027 | 20.12.2027 | 23.07.2027 | 09.02.2029 | 14.02.2028 | 01.12.2026 | 18.03.2030 | 20.03.2028 | 27.09.2028 | 26.04.2027 | 26.04.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
183,04 | 56,14 | 12,496 | 2 627,25 | 52,905 | 65,00 | 425,25 | 63,504 | 57,20 | 50,768 | 61,93 | 119,325 | 2 094,40 | 677,60 | 643,30 | 90,585 | 84,95 | 64,481 | 664,40 | 95,80 |
| rendement max. p.a. | - | 16,42% | -12,97% | 5,38% | 9,06% | 8,03% | - | 7,08% | 3,70% | 9,71% | 5,77% | 6,47% | 4,94% | 13,06% | 20,63% | 5,40% | 6,38% | 6,03% | 13,96% | 4,41% |
| Demande | 98,44 | 97,50 | 100,01 | 97,17 | 95,99 | 92,40 | - | 99,85 | 99,30 | 98,26 | 98,30 | 99,54 | 98,51 | 91,10 | 97,50 | 101,45 | 101,10 | 102,53 | 95,80 | 100,70 |
| Offre | - | 98,50 | 100,91 | 97,97 | 96,79 | 93,60 | - | 100,65 | 100,50 | 99,06 | 99,30 | 100,34 | 99,31 | 92,10 | 98,50 | 102,45 | 102,10 | 103,35 | 96,80 | 101,90 |